Kashif Rafiq Zahid
Overview
Explore the profile of Kashif Rafiq Zahid including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
214
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anwar S, Peng J, Zahid K, Zhou Y, Ali Q, Qiu C
Adv Respir Med
. 2024 Jul;
92(4):263-277.
PMID: 39051188
A common life-threatening hereditary disease, Cystic Fibrosis (CF), affects primarily Caucasian infants. High sweat-salt levels are observed as a result of a single autosomal mutation in chromosome 7 that affects...
2.
Huang X, Dai Z, Zeng B, Xiao X, Zahid K, Lin X, et al.
Hum Cell
. 2024 Jun;
37(5):1489-1504.
PMID: 38935235
The limited response of hepatocellular carcinoma (HCC) to chemotherapy drugs has always been a bottleneck in therapy. DNA damage repair is a major reason for chemoresistance. Previous studies have confirmed...
3.
Tumbath S, Jiang L, Li X, Zhang T, Zahid K, Zhao Y, et al.
Oncoimmunology
. 2024 Jun;
13(1):2363000.
PMID: 38846085
NAD(P)H:quinone oxidoreductase 1 (NQO1) is overexpressed in most solid cancers, emerging as a promising target for tumor-selective killing. β-Lapachone (β-Lap), an NQO1 bioactivatable drug, exhibits significant antitumor effects on NQO1-positive...
4.
Sun R, Shao X, Akter F, Zahid K, Yao S, Ma L, et al.
Cancer Genomics Proteomics
. 2024 Feb;
21(2):186-202.
PMID: 38423596
Background/aim: Gliomas are the most prevalent brain tumors with metabolic alterations playing a pivotal role in disease progression. However, the precise coordination of metabolic alterations with tumor-promoting cellular mechanisms, leading...
5.
Wang J, Su X, Jiang L, Boudreau M, Chatkewitz L, Kilgore J, et al.
Cancers (Basel)
. 2023 Dec;
15(24).
PMID: 38136388
Lung and breast cancers rank as two of the most common and lethal tumors, accounting for a substantial number of cancer-related deaths worldwide. While the past two decades have witnessed...
6.
Xiao X, Huang Q, Lin X, Zahid K, Huang X, Liu T, et al.
Anal Methods
. 2023 Dec;
16(2):152-160.
PMID: 38108085
Glypican-3 (GPC3) is a heparan sulfate proteoglycan (HSPG) that binds to the cell membrane glycosylphosphatidylinositol (GPI), widely expressed in human embryos, and is undetectable in healthy adult liver but overexpressed...
7.
Jiang L, Liu Y, Tumbath S, Boudreau M, Chatkewitz L, Wang J, et al.
Antioxid Redox Signal
. 2023 Nov;
41(1-3):74-92.
PMID: 37950707
Pancreatic cancer is among the top five leading causes of cancer-related deaths worldwide, with poor overall survival rates. Current therapies for pancreatic cancer lack tumor specificity, resulting in harmful effects...
8.
Ubil E, Zahid K
Front Immunol
. 2023 Nov;
14:1244170.
PMID: 37936688
Immunotherapy is a promising therapeutic tool that promotes the elimination of cancerous cells by a patient's own immune system. However, in the clinical setting, the number of cancer patients benefitting...
9.
H Al-Zuaini H, Zahid K, Xiao X, Raza U, Huang Q, Zeng T
Front Oncol
. 2023 Aug;
13:1207253.
PMID: 37583933
Low oxygen tension, or hypoxia is the driving force behind tumor aggressiveness, leading to therapy resistance, metastasis, and stemness in solid cancers including breast cancer, which now stands as the...
10.
Mei L, Shen H, Yu Y, Weng Y, Li X, Zahid K, et al.
Biomed Opt Express
. 2023 Jan;
13(12):6631-6644.
PMID: 36589588
Multiple myeloma (MM) is a type of blood cancer where plasma cells abnormally multiply and crowd out regular blood cells in the bones. Automated analysis of bone marrow smear examination...